Skip Navigation

A Phase II study of TAS-102 in metastatic Platinum and checkpoint inhibitor?resistant bladder cancer

Brief Summary

Type:
Bladder

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT03762161

Study #:
STUDY00143276

Start Date:
Jan 02, 2019

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03762161

View Complete Trial Details & Eligibility at ClinicalTrials.gov